Co-Authors
This is a "connection" page, showing publications co-authored by Bryan McVerry and Tami Minnier.
Connection Strength
0.059
-
The UPMC OPTIMISE-C19 (OPtimizing Treatment and Impact of Monoclonal antIbodieS through Evaluation for COVID-19) trial: a structured summary of a study protocol for an open-label, pragmatic, comparative effectiveness platform trial with response-adaptive randomization. Trials. 2021 May 25; 22(1):363.
Score: 0.059